Malnutrition in dialysis: Malnourishment or uremic inflammatory response?

Kidney International

Volumn 57, Issue 3, 2000, Pages 1211-1232

  Riella, Miguel C ^a,b  

^a Gynecology Department   (Brazil)

^b Evangelic School of Medicine   (Brazil)

Author keywords

Acute phase reactants; C reactive protein; Continuous ambulatory peritoneal dialysis; Cytokines; Hemodialysis; Homocysteinemia; Hypoalbuminemia; Leptin; Metabolic acidosis; Uremic toxin

Indexed keywords

C REACTIVE PROTEIN; SERUM ALBUMIN;

ADULT; ANOREXIA; BACTERIAL PERITONITIS; BODY MASS; CASE REPORT; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; EDEMA; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; LABORATORY TEST; MALNUTRITION; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; UREMIA;

EID: 0033931357     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ki.4491447     Document Type: Conference Paper

References (128)

1. 1. BERGSTRÖM J, LINDHOLM B: Nutrition and adequacy of dialysis: How do hemodialysis and CAPD compare? Kidney Int 43(Suppl 40):S39-S50, 1993
2. 2. ALLMAN MA, ALLEN BJ, STEWART PM, BLAGOJEVIC N, TILLER DJ, GASKIN KJ, TRUSWELL AS: Body protein of patients undergoing hemodialysis. Eur J Clin Nutr 44:123-131, 1990
3. 3. GUARNIERI G, TOIGL G, SITULIN R, FACCINI L, COLI U, LANNINI S, BAZZATO G, DARDI F, CAMPANACCI L: Muscle biopsy studies in chronically uremic patients: Evidence for malnutrition. Kidney Int 24(Suppl 16):S187-S193, 1983
4. 4. BERGSTRÖM J, ALVESTRAND A, FÜRST P: Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 38:108-114, 1990
5. 5. TALEMAITOGA AS, SANDERS BA, HINTON D, LIYNN KL: Nutritional status of home hemodialysis patients. Aust N Z J Med 19:303-309, 1989
6. 6. BERGSTRÖM J: Nutrition and mortality in hemodialysis. J Am Soc Nephrol 6:1329-1341, 1995
7. 7. RAYNER HC, SROUD DB, SALAMON KM, STRAUSS BJ, THOMSON NM, ATKINS RC, WAHLQVIST ML: Anthropometry underestimates body protein depletion in hemodialysis patients. Nephron 59:33-40, 1991
8. 8. LEAVEY SF, STRAWDERMAN RL, JONES CA, PORT FK, HELD PJ: Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 31:997-1006, 1998
9. 9. YOUNG GA, KOPPLE JD, LINDHOLM B, VONESH EF, DE VECCHI A, SCALAMOGNA A, CASTELNOVA C, OREOPOULOS DG, ANDERSON GH, BERGSTRÖM J, DICHIRO J, GENTILE D, NISSENSON AL, SAKHRANI L, BROWNJOHN AM, NOLPH KD, PROWANI BF, ALGRIM CE, MARTIS L, SERKES KD: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 17:462-471, 1991
10. 10. OKSA H, AHONEN K, PASTERNAK A, MARNELA KM: Malnutrition in hemodialysis patients. Scand J Urol Nephrol 25:157-161, 1991
11. 11. BERGSTRÖM J, HEIMBÜRGER O, LINDHOLM B: Calculation of the protein equivalent of total nitrogen appearance from urea appearance: Which formulas should be used? Perit Dial Int 18:467-473, 1998
12. 12. YOUNG VR: Nutritional requirements of normal adults, in Handbook of Nutrition and the Kidney (3rd ed), edited by MITCH WE, KLAHR S, New York, Lippincott-Raven, 1998, p 1
13. 13. AHMED KR, KOPPLE JD: Nutrition in maintenance hemodialysis patients, in Nutritional Management of Renal Disease, edited by KOPPLE JD, MASSRY SG, Baltimore, Williams & Wilkins, 1997, p 563
14. 14. MONTEON FJ, LAIDLAW AS, SHAIB JK, KOPPLE JD: Energy expenditure in patients with chronic renal failure. Kidney Int 30:741-747, 1986
15. 15. IKIZLER TA, WINGARD RL, SUN M, HARVELL J, PARKER RA, HAKIM RM: Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol 7:2646-2653, 1996
16. 16. WOLFSON M, STRONG CJ, MINTURN D, GRAY KD, KOPPLE JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 37:547-555, 1984
17. 17. SLOMOWITZ LA, MONTEON FJ, GROSVENOR M, LAIDLAW AS, KOPPLE JD: Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 35:704-711, 1989
18. 18. SCHOENFELD PY, HENRY RR, LAIRD NM, ROXE DM: Assessment of nutritional status of the National Cooperative Study population. Kidney Int 23:S80-S88, 1983
19. 19. MARONI BJ, STEINMAN TI, MITCH WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27:58-65, 1985
20. 20. IKIZLER TA, GREENE J, WINGARD RL, PARKER RA, HAKIM RM: Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6:1386-1391, 1995
21. 21. BERGSTRÖM J, FÜRST P, ALVESTRAND A, LINDHOLM B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44:1048-1057, 1993
22. 22. LINDSAY RM, SPANNER E: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 13:382-389, 1989
23. 23. LOWRIE EG, LAIRD NM, HENRY RR: Protocol for the National Cooperative Dialysis Study. Kidney Int 23(Suppl 13):S11-S18, 1983
24. 24. MOVILLI E, MOMBELLONI S, GAGGIOTTI M, MAIORCA R: Effect of age on protein catabolic rate, morbidity, and mortality in uraemic patients with adequate dialysis. Nephrol Dial Transplant 8:735-739, 1993
25. 25. HAKIM RM, BREYER J, ISMAIL N, SCHULMAN G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23:661-669, 1994
26. 26. LOWRIE EG: Chronic dialysis treatment: Clinical outcome and related processes of care. Am J Kidney Dis 24:255-266, 1994
27. 27. BURROWES JD, LYONS TA, KAUFMAN AM, LEVIN NW: Improvement in serum albumin with adequate hemodialysis. J Ren Nutr 3:171-176, 1993
28. 28. OWEN WF, LEW ML, LIU Y, LOWRIE EG, LAZARUS JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006, 1993
29. 29. LAMFIRE NH, VANHOLDER R, VEYT D, LAMBERT MC, RINGOIR S: A longitudinal, five-year study of urea kinetic parameters in CAPD patients. Kidney Int 42:426-432, 1992
30. 30. ANDERSTAM B, MAMOUN AH, SÖDERSTEN P, BERGSTRÖM J: Middle molecules (MM) isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 7:2453-2460, 1996
31. 31. ZHANG Y, PROENCA R, MAFFEI M, BARONE M, LEOPOLD L, FRIEDMAN JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
32. 32. DAGOGO-JACK S: Uremic hyperleptinemia: Adaptive or maladaptive? Kidney Int 54:997-998, 1998
33. 33. KALRA SP, KALRA PS: Is neuropeptide Y a naturally occurring appetite transducer? Curr Opin Endocrinol Diabetes 3:157-163, 1996
34. 34. CHEN H, CHARLAT O, TARTAGLIA LA, WOOLF EA, WENGH X, ELLIS S, LAKEY NE, CULPEPPER J, MOORE KJ, BREITBART RE, DUYK GM, TEPPER RI, MORGENSTERN JP: Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495, 1996
35. 35. SAAD MF, KHAN A, SHARMA A, MICHAEL R, RIAD-GABRIEL MG, BOYADJIAN R, JINAGOUDA SD, STEIL GM, KAMDAR V: Physiological insulinemia acutely modulates plasma leptin. Diabetes 47:544-549, 1998
36. 36. SHARMA K, CONSIDINE RV, MICHAEL B, DUNN SR, WEISBERG LS, KURNIK BR, KURNIK PB, O'CONNOR J, SINHA M, CARO JF: Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51:1980-1985, 1997
37. 37. DAGOGO-JACK S, OVALLE F, GEARY B, LANDT M, COYNE DW: Hyperleptinemia in patients with end-stage renal disease treated by continuous ambulatory peritoneal dialysis. Perit Dial Int 18:34-40, 1998
38. 38. NISHIZAWA Y, SHOJI T, TANAKA S, YAMASHITA M, MORITA A, EMOTO M, TABATA T, INOUE T, MORII H: Plasma leptin levels and its relationship with body composition in hemodialysis patients. Am J Kidney Dis 31:655-661, 1998
39. 39. HEIMBÜRGER O, LÖNNQVIST F, DANIELSSON A, NORDENSTRÖM J, STENVINKEL P: Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8:1423-1430, 1997
40. 40. MOLDAWER LL, ANDERSSON C, GELIN J, LLUNDHOLM KG: Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol 254:G450-G456, 1988
41. 41. KAIZU Y, KIMURA M, YONEYAMA T, MIYAJI K, HIBI I, KUMAGAI H: Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 31:93-100, 1998
42. 42. BERGSTRÖM J: Why are dialysis patients malnourished? Am J Kidney Dis 26:229-241, 1995
43. 43. MITCH WE, CLARK AS: Muscle protein turnover in uremia. Kidney Int 24:S2-S8, 1983
44. 44. LIM VS, BIER DM, FLANIGAN MJ, SUM-PING ST: The effect of hemodialysis on protein metabolism. J Clin Invest 91:2429-2436, 1993
45. 13C-leucine. Am J Clin Nutr 46:778-783, 1987
46. 46. GOODSHIP THJ, LLOYD S, CLAGUE MB, BARTLETI K, WARD MK, WILKINSON R: Whole body leucine turnover and nutritional status in continuous ambulatory peritoneal dialysis. Clin Sci 73:463-469, 1987
47. 47. BAILEY JL, MITCH WE: Does metabolic acidosis have clinically important consequences in dialysis patients? Semin Dial 11:23-24, 1998
48. 48. MAY RC, MASUD T, LOGUE B, BAILEY J, ENGLAND B: Chronic metabolic acidosis accelerates whole body proteolysis and oxidation in awake rats. Kidney Int 41:1535-1542, 1992
49. 49. WILLIAMS B, HATTERSLEY J, LAYWARD E, WALLS J: Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. Kidney Int 40:779-786, 1991
50. 50. BALLMER PE, MCNURLAN MA, HULIER HN, ANDERSON SE, GARLICK PJ, KRAPF R: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 95:39-45, 1995
51. 51. REAICH D, CHANNON SM, SCRIMGEOUR CM, DALEI SE, WILKINSON R, GOODSHIP THJ: Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 265:E230-E235, 1993
52. 52. GRAHAM KA, REAICH D, CHANNON SM, DOWNIE S, GILMOUR E, PASSLICK-DEETJEN J, GOODSHIP THJ: Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 49:1396-1400, 1996
53. 53. LIM VS, YARASHESKI KE, FLANIGAN MJ: The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: A longitudinal leucine kinetic study. Nephrol Dial Transplant 13:1723-1730, 1998
54. 54. GOODSHIP THJ, MITCH WE, HOERR RA, WAGNER DA, STEINMAN TI, YOUNG VR: Adaptation to low-protein diets in renal failure: Leucine turnover and nitrogen balance. J Am Soc Nephrol 1:66-75, 1990
55. 55. GRAHAM KA, REAICH D, CHANNON SM, DOWNIE S, GOODSHIP THJ: Correction of acidosis in hemodialysis decreases whole body protein degradation. J Am Soc Nephrol 8:632-637, 1997
56. 56. LOWRIE EG, LEW NL: Commonly measured laboratory variables in hemodialysis patients: Relationships among them and to death risk. Semin Nephrol 12:276-283, 1992
57. 57. BRADY JP, HASBARGEN JA: Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. Am J Kidney Dis 31:35-40, 1998
58. 58. MOVILLI E, ZANI R, CARLO O, SANGALLI L, POLA A, CAMERINI C, CANCARINI GC, SCOLARI F, FELLER P, MAIORCA R: Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetieally evaluated protein intake in haemodialysis patients: A prospective study. Nephrol Dial Transplant 13:1719-1722, 1998
59. 59. WILLIAMS AJ, DITTMER ID, MCARLEY A, CLARKE J: High bicarbonate dialysate in haemodialysis patients: Effects on acidosis and nutritional status. Nephrol Dial Transplant 12:2633-2637, 1997
60. 60. STEIN A, MOORHOUSE J, ILES-SMITH H, BAKER F, JOHNSTONE J, JAMES G, TROUGHTON J, BIRCHER G, WALLS J: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52:1089-1095, 1997
61. 61. WARD RA, SHIRLOW MJ, HAYES JM, CHAPMAN GV, FARRET PC: Protein catabolism during hemodialysis. Am J Clin Nutr 32:2443-2449, 1979
62. 62. GUTIERREZ Z, BERGSTRÖM J, ALVESTRAND A: Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid. Kidney Int 46:814-822, 1994
63. 63. IKIZLER TA, FLAKOLL PJ, PARKER RA, HAKIM RM: Amino acid and albumin losses during hemodialysis. Kidney Int 46:830-837, 1994
64. 64. KAPLAN AA, HALLEY SE, LAPKIN RA, GRAEBER CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 47:573-578, 1995
65. 65. GUTIERREZ A, ALVESTRAND A, WAHREND J, BERGSTRÖM J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 38:487-494, 1990
66. 66. GUTIERREZ A, BERGSTRÖM J, ALVESTRAND A: Protein catabolism in sham hemodialysis: The effect of different membranes. Clin Nephrol 38:20-29, 1992
67. 67. KAYSEN GA, RATHORE V, SHEARER GC, DEPNER TA: Mechanisms of hypoalbuminuria in hemodialysis patients. Kidney Int 48:510-516, 1995
68. 68. KAYSEN GA, STEVENSON FT, DEPNER TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29:658-668, 1997
69. 69. STEVENSON FT: Inflammation and end-stage renal disease: Recent insights. Semin Dial 11:119-123, 1998
70. 70. LOWRIE EG: Conceptual model for a core pathobiology of uremia, with special reference to anemia, malnourishment and mortality among dialysis patients. Semin Dial 10:115-129, 1997
71. 71. KAYSEN GA: Hypoalbuminemia in dialysis patients. Semin Dial 9:249-256, 1996
72. 72. GIRNDT M, SESTER U, KAUL H, KOHLER H: Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level. J Am Soc Nephrol 9:1689-1696, 1998
73. 73. HERBELIN A, URENA P, NGUYEN AT, ZINGRAFF J, DESCHAMPS-LATSCHA B: Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 39:954-960, 1991
74. 74. NAKANISHI I, MOUTABARRIK A, OKADA N: Interleukin-8 in chronic renal failure and dialysis patients. Nephrol Dial Transplant 9:1435-1442, 1994
75. 75. ZAWI P, HAKIM RM: The effect of the dialysis membrane on cytokine release. J Am Soc Nephrol 4:1711-1718, 1994
76. 76. STRASSMANN G, FONG M, KENNEY JS, JACOB CO: Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89:1681-1684, 1992
77. 77. KEHAYIAS KAJ, ROUBENOFF R, SCHMID CH, PEREIRA BJ: Cytokine production and nutritional status in hemodialysis patients. Int J Artif Organs 21:4-11, 1998
78. 78. RIDKER PM, CUSHMAN M, STAMPFEER MJ, TRACY RP, HENNEKENS CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
79. 79. United States Renal Data System (USRDS) Report. Bethesda, US Department of Health and Human Services, Public Health Service, National Institutes of Health, April, 1998, p 79
80. 80. BERGSTRÖM J, LINDHOLM B: Malnutrition, cardiac disease and mortality: An integrated point of view. Am J Kidney Dis 32:834-841, 1998
81. 81. FOLEY RN, PARFREY OS, HARNETT JD, KENT GM, MURRAY DC, BARRE PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7:728-736, 1996
82. 82. ROSS R: Atherosclerosis: An inflammatory disease. N Engl J Med 340:115-126, 1999
83. 83. SENTI M, ROMERO R, PEDRO-BOTET J, PELEGRI A, NOGUES X, RUBIES-PRAI J: Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 41:1394-1399, 1992
84. 84. CRESSMAN MD, HOOGWERF BJ, SCHREIBER MJ, CONSENTINO FA: Lipid abnormalities and end-stage renal disease: Implications for atherosclerotic cardiovascular disease? Miner Electrolyte Metab 19:180-185, 1993
85. 85. WADE DP, CLARKE JG, LINDAHL DG: Control regions of the apolipoprotein (a) gene and members of the related plasminogen family. Proc Natl Acad Sci USA 90:1369-1373, 1993
86. 86. MAEDA S, ABE A, SEISHIMA M, KAKINO K, NOMA A, KAWADE M: Transient changes of serum lipoprotein (a) as an acute phase protein. Atherosclerosis 78:145-150, 1989
87. 87. KARIO K, MATSUO T, KOBAYASHI H, MATSUO M, ASADA R, KOIDE M: High lipoprotein(a) levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb Haemost 74:1020-1024, 1995
88. 88. STEINVINKEL P, HELMBURGER O, TUCK C, BERGLUND L: Apo (a)-isoform size and nutritional status in patients with chronic renal failure. Kidney Int 53:1336-1342, 1998
89. 89. GUPTA A, ROBINSON K: Hyperhomocysteinaemia and end stage renal disease. J Nephrol 10:77-84, 1997
90. 90. WILCKEN DEL, WILCKEN B: The pathogenesis of coronary artery disease: A possible role for methionine metabolism. J Clin Invest 57:1079-1082, 1976
91. 91. HEINRICH J, SCHULTE H, SCHONTELT R, KOHLER R, ASSMAN G: Association of variables of coagulation, fibrinolysis and acutephase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 73:373-379, 1995
92. 92. LIUZZO G, LUIGI M, GALLIMORE JG, GRILIO RL, REBUZZI A, PEPYS MB, MASERI A: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331:417-424, 1994
93. 93. ALEXANDER RW: Inflammation and coronary heart disease. N Engl J Med 331:468-469, 1994
94. 94. MENDALL MA, PATEL L, STRACHAN D, NORTHFIELD TC: C-reactive protein and its relation to cardiovascular risk factors: A population based cross section study. Br Med J 312:1061-1065, 1996
95. 95. STAHL WM: Acute phase protein response to tissue injury. Crit Care Med 15:545-550, 1987
96. 96. OWEN WF, LOWRIE EG: C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54:627-636, 1998
97. 97. HAN DS, LEE SW, KANG SW, CHOI KH, LEE HY, CHO EY, LEE JH: Factors affecting low values of serum albumin in CAPD patients. Adv Perit Dial 12:288-292, 1996
98. 98. ZIMMERMANN J, HERRLINGER S, PRUY A, METZGER T, WANNER C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
99. 99. SHAPIRO JI, ARGY WP, RAKOWSKY TA, CHESTER A, SIEMSEN AS, SCHREINER GE: The unsuitability of BUN as a criterion for prescription dialysis. ASAIO Trans 29:129-134, 1983
100. 100. ACCHIARDO SR, MOORE LW, LATOUR PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 24:199-203, 1983
101. 101. LOWRIE EG, LEW NL, HUANG WH: Race and diabetes as death risk predictors in hemodialysis patients. Kidney Int 42(Suppl 39):S22-S31, 1992
102. 102. TEEHAN BP, SCHLFIFER CR, BROWN JM, SIGLER MH, RAIMONDO J: Urea kinetic analysis and clinical outcome on CAPD: A five year longitudinal study. Adv Perit Dial 6:181-185, 1990
103. 103. KOPPLE JD: Effect of nutrition and morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 24:1002-1009, 1994
104. 104. CHERTOW GM, LING J, LEW NL, LAZARUS MJ, LOWRIE EG: The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 24:912-920, 1994
105. 105. MOESLINGER T, FRIEDI R, VOLF I, BRUNNER M, BARAN H, KOLLER E, SPIECKERMANN G: Urea induces macrophage proliferation by inhibition of inducible nitric oxide synthesis. Kidney Int 56:581-588, 1999
106. 106. WIGMORE SJ, FEARON KC, MAINGAY JP, ROSS JA: Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin 6. Clin Sci (Colch) 92:215-221, 1997
107. 107. BARBER MD, ROSS JA, VOSS AC, TISDALE MJ, FEARON KC: The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81:80-86, 1999
108. 108. RIDKER PM, CUSHMAN M, STAMPFER MJ, TRACY RP, HENNEKENS CH: Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. J Engl J Med 336:973-979, 1997
109. 109. RIDKER PM: Inflammation, atherosclerosis, and cardiovascular risk: An epidemiologic view. Blood Coagul Fibrinolysis 10(Suppl 1):S9-S12, 1999
110. 110. PERTOSA G, GRANDALIANO G, GESUALDO L, RANIERI E, MONNO R, SCHENA FP: Interleukin-6, interleukin-8, and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes. Kidney Int 54:570-579, 1998
111. 111. FENTON SSA, SCHAUBEL DE, DESMEULES M, MORRISON HI, MAO Y, COPLESTON P, JEFFREY JR, KJELLSTRAND CM: Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 30:334-342, 1997
112. 112. AGUILERA A, CODOCEO R, SELGAS R, GARCIA P, PICORNELL M, DIAZ C, SANCHEZ C, BAJO MA: Anorexigen (TNF-α, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: Their relationship with nutritional parameters. Nephrol Dial Transplant 13:1476-1483, 1998
113. 113. CHERTOW GM, LOWRIE EG, WILMORE DE, GONZALEZ J, LEW NL, LING J, LEBOFF MS, GOTTLIEB MN, HUANG W, ZEBROWSKI G, COLLEGE J, LAZARUS MJ: Nutritional assessment with bioclectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol 6:75-81, 1995
114. 114. KAGAN A, HARAN N, LESCHINSKY L, SHUALI N, RAPOPORI J: Leptin in CAPD patients: Serum concentrations and peritoneal loss. Nephrol Dial Transplant 14:400-405, 1999
115. 115. COYNE DW, DAGOGO-JACK S, KLEIN S, MFRABET E, AUDRAIN J, LANDT M: High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients. Am J Kidney Dis 32:1031-1035, 1998
116. 116. CONSENSUS GROUP STATEMENT: Role of L-carnitine in treating renal dialysis patients. Dial Transplant 23:177-181, 1994
117. 117. SIENVINKEL P, HOLMBERG I, HEIMBÜRGER O, DICZFALUSY U: A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure: Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 13:2594-2600, 1998
118. 118. TETA D, BEVINGTON A, BROWN J, THROSSEI D, HARRIS KP, WALLS J: Effects of acidosis on leptin secretion from 3T3-L1 adipocytes and on serum leptin in the uremic rat. Clin Sci (Colch) 97:363-368, 1999
119. 119. CHURCHILI DN: An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis 30:899-906, 1997
120. 120. KING AJ, KEHAYIAS JJ, ROUBENOFF R, SCHMID CH, PEREIRA BJ: Cytokine production and nutritional status in hemodialysis patients. Int J Artif Organs 21:4-11, 1998
121. 121. FLEISCHMANN E, TEAI N, DUDLEY J, MAY W, BOWER JD, SLAHUDEEN AK: Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560-1567, 1999
122. 122. JOHANNSSON G, BENGTSSON B-A, AHLMÉN J: Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement. Am J Kidney Dis 33:709-717, 1999
123. 123. VAISMAN N, ZADIK Z, DUCHAN R, VOET H, LOTAN D, DRUKKER A: Changes in body composition of children with chronic renal failure during growth hormone treatment. Pediatr Nephrol 8:201-204, 1994
124. 124. LAZARUS MJ: Recommended criteria for initiating and discontinuing intradialytic parenteral nutrition therapy. Am J Kidney Dis 33:211-216, 1999
125. 125. KIMMFL PL, PHILLIPS TM, SIMMENS SJ, PETERSON RA, WEINS KL, ALLEYNE S, CRUZ I, YANOVSKI JA, VEIS JH: Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244, 1998
126. 126. GENNARI FJ: Acid-base homeostasis in end-stage renal disease. Semin Dial 9:404-411, 1996
127. 127. GANSS R, AARSETH HP, NORDBY G: Prevention of hemodialysis associated hypoxemia by use of low-concentration bicarbonate dialysate. ASAIO J 38:820-822, 1992
128. 128. GARIBOTTO G, RUSSO R, SOFIA A, SLA MR, ROBAUDO C, MOSCATELLI P, DEFERRARI G, TIZIANELLO A: Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 45:1432-1439, 1994